Three drugmakers recently announced refunds to 340B covered entities for overcharges, while one announced NDC changes.

Three Drugmakers to Refund 340B Covered Entities for Overcharges, One Announces NDC Changes

April 30, 2026 Shannon Young, Managing Editor 340B Report Views

Three drugmakers recently announced refunds to 340B covered entities that purchased certain medications between 2024 and 2026, while a New [...]

Please Login or Become a Paid Subscriber to View this Content

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!